The Asia-Pacific breast reconstruction market refers to the regional healthcare sector dedicated to restoring breast aesthetics and function following mastectomies or other breast-related surgeries. Patients in the Asia-Pacific region are increasingly seeking personalized, patient-centric care, which has led to the development of innovative solutions and improved access to breast reconstruction procedures. Innovative techniques such as autologous tissue reconstruction and rising aesthetic concerns among patients contribute to market development. As a result, medical device companies and healthcare providers focus on introducing cutting-edge products and personalized solutions, fostering a thriving breast reconstruction market in the Asia-Pacific region.
Access Full Report @ https://www.databridgemarketresearch.com/reports/asia-pacific-breast-reconstruction-market
Data Bridge Market Research analyses that the Asia-Pacific Breast Reconstruction Market, which was USD 128.88 million in 2022, is expected to reach USD 266.38 million by 2030, at a CAGR of 9.5% from 2023 to 2030. Increasing awareness about breast cancer and the implementation of early detection campaigns have been instrumental in promoting timely diagnosis and treatment. This creates a higher demand for breast reconstruction options, as patients are increasingly inclined to consider post-mastectomy restoration of their natural breast contours.
Key Findings of the Study
Rising breast cancer incidence is expected to drive the market's growth rate
The escalating incidence of breast cancer in the Asia-Pacific region stands as a predominant driver for the breast reconstruction market. As breast cancer diagnoses continue to rise, an increasing number of patients undergo mastectomies as part of their treatment. Consequently, the demand for breast reconstruction procedures has grown substantially. This surge is driven by the need to help survivors regain their physical and emotional well-being, ensuring they can restore their natural appearance and self-esteem. In response to this growing need, the Asia-Pacific region has witnessed an expanding market for breast reconstruction procedures and related medical advancements.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021(Customizable to 2015-2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Breast Implants, Tissue Expanders, Acellular Dermal Matrix), Type (Unilateral, Bilateral), Shape (Round Implants, Anatomical Implants), Technology (Inframammary, Peri-Areolar, Trans-Axillary, Transumbilical), Placement (Dual-Plane Insertion, Subglandular Insertion, Submuscular Insertion), Procedure (Immediate Procedures, Delayed Procedures, Revision Procedures), End User (Hospitals, Cosmetology Clinics, Ambulatory Surgical Centers, Others)
|
|
Countries Covered
|
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC)
|
|
Market Players Covered
|
POLYTECH Health & Aesthetics GmbH (Germany), CEREPLAS (France), Guangzhou Wanhe Plastic Material Co., Ltd (China), Johnson & Johnson Private Limited (U.S.), GC Aesthetics (U.K.), Laboratories Arion (France), Sientra Inc. (U.S.), HANSBIOMED CO. LTD (South Korea), Sientra, Inc. (U.S.), Deal Implant Incorporated (U.S), Integra LifeSciences (U.S.), PMT Corporation (U.S.), RTI Surgical (U.S.), Establishment Labs S.A. (U.S.), Silimed (Brazil)
|
|
Data Points Covered in the Report
|
In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
|
Segment Analysis:
The Asia-Pacific breast reconstruction market is segmented on the basis of product, type, shape, technology, placement, procedure, and end user.
- On the basis of product the Asia-Pacific breast reconstruction market is segmented into breast implants, tissue expanders, and acellular dermal matrix.
- On the basis of type the Asia-Pacific breast reconstruction market is segmented into unilateral, and bilateral.
- On the basis of shape the Asia-Pacific breast reconstruction market is segmented into round implants, and anatomical implants.
- On the basis of technology the Asia-Pacific breast reconstruction market is segmented into inframammary, peri-areolar, trans-axillary, and transumbilical.
- On the basis of placement the Asia-Pacific breast reconstruction market is segmented into dual-plane insertion, subglandular insertion, and submuscular insertion.
- On the basis of procedure the Asia-Pacific breast reconstruction market is segmented into immediate procedures, delayed procedures, and revision procedures.
- On the basis of end user the Asia-Pacific breast reconstruction market is segmented into hospitals, cosmetology clinics, ambulatory surgical centers, and others.
Major Players
Data Bridge Market Research recognizes the following companies as the major Asia-Pacific breast reconstruction market players in the Asia-Pacific breast reconstruction market are Johnson & Johnson Private Limited (U.S.), GC Aesthetics (U.K.), Laboratories Arion (France), Sientra Inc. (U.S.), HANSBIOMED CO. LTD (South Korea), Sientra, Inc. (U.S.), Deal Implant Incorporated (U.S).
Market Developments
- In October 2022, China's Second Affiliated Hospital, School of Medicine, Zhejiang University, in partnership with Affiliated Hangzhou First People's Hospital, Zhejiang University, launched a clinical trial titled "Axillary Versus Primary Breast Approach for Second-stage Operation in Expander-Implant Breast Reconstruction." The study is expected to conclude by December 2024.
- In August 2022, BellaSeno GmbH, a medical technology manufacturer, revealed the commencement of human trials for their exclusive 3D-printed breast implants. These implants, constructed as fully resorbable scaffolds, are intended for use in breast regeneration, augmentation, or revision surgeries, gradually dissolving in the body over time. This innovative approach marks a significant step forward in breast surgery and implant technology.
- In April 2022, GC Aesthetics (GCA), a medical technology firm, disclosed its approval by the U.S. Food and Drug Administration for the LUNA xt micro-textured anatomical breast implant, a new addition to their product line, expanding their offerings in the field of breast implants in the United States.
- In May 2022, Prayasta 3D Inventions Pvt Ltd, a Pune-based startup, achieved national recognition by winning the 2022 National Technology Award from the Department of Science and Technology (DST). The company specializes in providing durable 3D breast implants and prosthetics, employing its innovative iEAM technology (elastomer additive manufacturing) developed in-house. This award acknowledges their pioneering contributions to the field of medical technology.
- In 2020, AbbVie Inc. successfully acquired Allergan, merging their product portfolios. This strategic move bolstered AbbVie's market presence and future product demand. By amalgamating both companies' offerings, it fortified their business, fostering a more competitive and diversified product range, poised to meet evolving market needs and enhance their position in the industry.
Regional Analysis
Geographically, the countries covered in the Asia-Pacific breast reconstruction market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
As per Data Bridge Market Research analysis:
Japan dominates in Asia-Pacific breast reconstruction market during the forecast period 2023-2030
Japan's prominence in the Asia-Pacific breast reconstruction market is attributed to a surging demand for aesthetic enhancements. The country boasts a sophisticated healthcare infrastructure, highly skilled surgeons, and a culture that values beauty. As a result, it attracts a significant number of patients seeking breast reconstruction for both medical and cosmetic reasons. This increasing demand and advanced medical technologies and rigorous quality standards position Japan as a dominant player in the regional breast reconstruction sector.
For more detailed information about the Asia-Pacific breast reconstruction market report, click here – https://www.databridgemarketresearch.com/reports/asia-pacific-breast-reconstruction-market
